Odysight.ai grants 60,000 stock options to CBO

Odysight.ai Inc. reported that its Chief Business Officer, Eilam Sagi, received a grant of stock options on January 25, 2026.

Rhea-AI Filing Summary

Odysight.ai Inc. reported that its Chief Business Officer, Eilam Sagi, received a grant of stock options on January 25, 2026. The award covers options to purchase 60,000 shares of common stock at an exercise price of $4.7 per share, with no cash paid for the grant itself.

According to the vesting terms, the option becomes exercisable for one-third of the shares on November 15, 2026, then vests in equal quarterly installments over the following 24 months, so that it is fully vested and exercisable on November 15, 2028. After this grant, Sagi beneficially owns 60,000 derivative securities directly.

Insider Trade Summary

Grant/Award: 60,000 shares

Grant/Award 1 txn

Insider Sagi Eilam

Role Chief Business Officer

Type	Security	Shares	Price	Value
Grant/Award	Options to purchase common stock (right to buy)	60,000	$0.00	$0.00

Holdings After Transaction: Options to purchase common stock (right to buy) — 60,000 contracts (Direct)

Footnotes (1)

1. F1. The stock option vests and becomes exercisable as to one-third of the total shares on November 15, 2026 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on November 15, 2028.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Odysight.ai (ODYS) disclose in this Form 4 filing?

The filing shows that Chief Business Officer Eilam Sagi received stock options for 60,000 shares of common stock on January 25, 2026.

What are the key terms of Eilam Sagis stock options at Odysight.ai (ODYS)?

The options allow Sagi to buy 60,000 shares of common stock at $4.7 per share, with the grant itself reported at a $0 price for the derivative security.

How do the 60,000 Odysight.ai (ODYS) stock options vest for the Chief Business Officer?

The option vests as to one-third of the shares on November 15, 2026, then in equal quarterly installments over the next 24 months, becoming fully vested on November 15, 2028.

How many derivative securities does Eilam Sagi own after this Odysight.ai (ODYS) option grant?

After the reported transaction, Sagi beneficially owns 60,000 derivative securities (stock options) directly.

Does this Odysight.ai (ODYS) Form 4 reflect a stock sale by Eilam Sagi?

No. The Form 4 reports a grant (code "A") of stock options, not a sale of common shares.

What role does the reporting person hold at Odysight.ai (ODYS)?

The reporting person, Eilam Sagi, is identified as the companys Chief Business Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/27/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sagi Eilam

(Last) (First) (Middle)

C/O ODYSIGHT AI INC.

SUITE 7A, INDUSTRIAL PARK, P.O. BOX 3030

(Street)

OMER L3 8496500

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Odysight.ai Inc. [ ODYS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Business Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to purchase common stock (right to buy)	$4.7	01/25/2026		A		60,000		(1)	01/25/2033	Common Stock	60,000	$0	60,000	D

Explanation of Responses:

1. The stock option vests and becomes exercisable as to one-third of the total shares on November 15, 2026 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on November 15, 2028.

	/s/ Eilam Sagi	01/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.